11th Protein Kinases in Drug Discovery Conference 2016
Hilton San Diego Bayfront Hotel *CALIFORNIA, USA Visit the Venue to read more
We invite you to attend the 11th Protein Kinases in Drug Discovery Conference, which will take place February 24 - 25, 2016 in San Diego, CA.
Over the past decades, protein kinases have proven to be an important class of drug targets for the pharmaceutical industry. This meeting seeks to create a forum for scientists from both industry and academia to gather and discuss the most recent advances in kinase inhibitor research. Leading researchers will present on hot topics such as irreversible inhibitors, allosteric inhibitors, and many more. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how kinase inhibitor discovery will continue to expand beyond oncology into applications in CNS disorders, inflammation, and more.
We hope to see you there!
The 2016 Advisory Committee
Professor, Molecular Medicine
University of Leicester
Group Leader, Signalling Networks in Cancer Group
Cancer Research UK Manchester Institute
Edinburgh Cancer Research Centre
University of Edinburgh
Senior Principal Scientist
Chief Executive Officer
Associate Professor, Biochemistry and Molecular Biology
University of Southern Denmark
Cancer Research UK Manchester Institute
Chair Pharmaceutical / Medicinal Chemistry, Department Pharmacy & Biochemistry
Eberhard Karls University Tuebingen
Global Discovery Chemistry, NIBR
Computational Scientist, Medicinal Chemistry
Professor, Medical Biochemistry and Cell Biology
University of Gothenburg
Team Leader/Lecturer, Surgery and Cancer
Imperial College London
Team Leader, Oncology Chemistry
Professor, Biomedical Sciences
University of Padova
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
San Diego is known for its mild year-round climate, natural deep-water harbor, extensive beaches, and recent emergence as a healthcare and biotechnology development center. The presence of the University of California, San Diego (UCSD), with the affiliated UCSD Medical Center, has helped make the area a center of research in biotechnology.
As of 2013, San Diego has the second-largest biotech cluster in the United States, below the Boston area and above the San Francisco Bay Area. There are more than 400 biotechnology companies in the area. In particular, the La Jolla and nearby Sorrento Valley areas are home to offices and research facilities for numerous biotechnology companies. Major biotechnology companies like Neurocrine Biosciences and Nventa Biopharmaceuticals are headquartered in San Diego, while many biotech and pharmaceutical companies, such as BD Biosciences, Biogen Idec, Integrated DNA Technologies, Merck, Pfizer, Élan, Celgene, and Vertex, have offices or research facilities in San Diego.
There are also several non-profit biotech and health care institutes, such as the Salk Institute for Biological Studies, the Scripps Research Institute, the West Wireless Health Institute and the Sanford-Burnham Institute. San Diego is also home to more than 140 contract research organizations (CROs) that provide a variety of contract services for pharmaceutical and biotechnology companies.
GTCbio encourages attendees to gain exposure by presenting their work in the poster sessions. Your research will be seen by leaders from top pharmaceutical, biotech, academic and government institutions, and will also be published in the conference materials. The top 2-3 qualified submitted abstracts will also be selected by the meeting's scientific advisory board for the chance to give a short oral presentation in the conference program.
Deadline to submit abstracts for poster presentations: January 24, 2015
Click here to submit an abstract. Complete all fields. Maximum number of words is 250 and maximum number of characters is 2,500. If possible, attach a document (.doc, .docx, or .pdf) should your abstract exceed the maximum number of words.
Deadline to register and secure your poster board slot: February 10, 2015
Please note that submitting your abstract does NOT guarantee you a poster board at the meeting. GTCbio reserves poster boards based on the number of delegates whose abstracts have been approved and have registered and paid in full for the conference. Any abstracts submitted after the registration deadline will not be guaranteed a poster board.
You will be notified by the conference organizers via email as soon as your submission has been reviewed.
Posters accepted by the deadline will be considered for oral presentation one month prior to the conference.
Posters submitted after the deadline will be considered for poster presentation only.
Oral presentation winners will be notified via email or telephone 2-3 weeks before the conference.
Selected oral presenters will be posted on the agenda.
You must be registered for the conference to present at the poster session.
Conference program posters must be relevant to the main conference topics.
POSTER SIZE AND SET UP:
Poster boards are 4 feet in width by 6 feet in height. (122 cm by 182 cm). Posters should be portrait orientation, with maximum dimensions to fit on the board accordingly. If accepted for the poster session, an email will be sent with details on when and where to pin your poster. Pins will be provided.
For more information on customized packages, multi-conference sponsorship packages and networking opportunities, please contact:
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com